Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta-analysisBrian G. Feagan, John K MacDonald|Inflammatory Bowel Diseases|2012Cited by 60
Etrolizumab for induction of remission in ulcerative colitisGreg Rosenfeld, Brian Bressler, Claire E Parker et al.|Cochrane Database of Systematic Reviews|2015Cited by 10